Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.
about
Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?Alcoholic liver disease: pathogenesis, management, and novel targets for therapyLeaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitisIL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in miceRole of innate immunity in the development of hepatocellular carcinomaAlcoholic liver disease: pathogenesis and new therapeutic targets.Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunctionMyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in MiceRole of interleukin-22 in liver diseases.Fibrogenesis in alcoholic liver disease.Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytesBoth bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.Pathogenesis of alcoholic liver disease: role of oxidative metabolism.Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancerAlcohol and inflammation and infection: clinical and experimental systems--summary of the 2010 Alcohol and Immunology Research Interest Group MeetingHepatoprotective and anti-inflammatory cytokines in alcoholic liver diseaseMetabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease.Toll-like receptors in liver fibrosis: cellular crosstalk and mechanismsImmunity and inflammatory signaling in alcoholic liver disease.New Approaches for Studying Alcoholic Liver DiseaseThe intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease.Binge ethanol and liver: new molecular developmentsAutophagy in alcohol-induced liver diseases.Inflammation in alcoholic liver disease.Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitisRecent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease.NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease.Gut-liver axis and sensing microbes.Hepatic stellate cells and innate immunity in alcoholic liver disease.Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.Role of toll-like receptors in immune activation and tolerance in the liver.Hepatitis C, innate immunity and alcohol: friends or foes?Scoparone Inhibits LPS-Simulated Inflammatory Response by Suppressing IRF3 and ERK in BV-2 Microglial Cells.Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells.Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response.ADAR1 Prevents Liver Injury from Inflammation and Suppresses Interferon Production in Hepatocytes.
P2860
Q26798033-5C004D9F-47DF-42C7-B926-A697081DA66BQ26861620-D7E40864-379F-48D0-A575-F7CD7D869648Q26991664-FB7CF87B-9FBF-4BB4-B79A-8E646B8CA9A2Q27008536-147AF779-91B8-457B-97FD-28FE469EC110Q27024780-A2174943-D857-4ABA-822B-7512B7DAB1DDQ27690220-2CF306D6-BD78-45FA-AE7E-A993EB1BF726Q28082228-01F2C8F5-7193-480E-90B9-CE302CA19009Q33569870-962145C5-BF86-48B1-A3B0-51BE903B0C7FQ33600346-2587B443-9DAE-4D8D-93F7-2A2F0B96EECBQ33729412-228CC4A8-8279-4B49-BDE2-5BDD1D7648A1Q33845463-E30A38FB-1C84-46D7-9358-3D543B851D84Q34036392-850BB4A1-F053-4A0C-9024-163CFCD50A7FQ34214279-D83ECC53-1989-4FE1-A689-875E21E853AEQ34589665-29D33DAD-79CC-4A1F-B2DD-E8A316975F5BQ34750539-C0F32287-F40E-4AEF-AFA4-A0F4758715C7Q35012716-2EAE9DA7-E48B-4B12-B626-FBFB51471A9EQ35066004-C6BED50C-336B-4EF2-A680-3062B979857EQ35656152-881104B7-2ADA-4A7F-8137-40DBB4884087Q35762773-7278D553-3D36-43EF-8A13-6AB2C97483D2Q35850014-1A949412-F300-4596-85BC-879AA5C6C9F4Q35977675-E9D13290-BA89-4191-A74D-BC7575AA15C9Q36104223-960ECA23-8262-4CF6-9C0E-D40803D9A2C7Q36288405-F402A270-93FB-4796-A24F-6A880ABB6E67Q36310293-CA5B629B-A179-4692-8452-3B6F87DC954EQ36798710-55056E3F-17D9-45D6-AC09-1FE6EC93D268Q36842295-F57CE56D-F172-4A33-98EF-9B09E45160BEQ36895048-D4E27018-D080-4F6A-B420-86D24284CF56Q37040722-C6C14491-F4A8-40A0-BA83-7DB41DCEB3CFQ37121662-5B4B4272-11E1-48CB-B669-A5E86FC1708DQ37236401-ED08524D-BEBD-44FD-A5B2-215C417B351DQ37739608-ECFBB257-4B09-400B-826A-AA34AD5663F1Q37869765-0D3DF07B-D5D2-477E-B55D-A4AC3EE138D6Q37883935-F2869469-4106-4368-8712-B9B033F3E0DFQ37962297-BF779430-59DD-4C44-BD0D-0E70EA8C4BA3Q38218115-B6AAFBD3-6AD4-4C4A-A8B8-5E06FC1F7336Q38349031-A1912980-D619-4226-BF83-9E9182A8326CQ38725907-2226E927-313E-47F8-AF37-542EECD90210Q38816350-5B5920DA-FD71-40A9-B378-ABA24EDAE252Q40012493-319AF9FC-95BA-4C32-BDA6-BBDD403101A9Q41760086-69203BB3-585E-47DC-BD96-9A3DFA56502E
P2860
Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@ast
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@en
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@nl
type
label
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@ast
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@en
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@nl
prefLabel
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@ast
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@en
Interferon regulatory factor 3 ...... parenchymal and myeloid cells.
@nl
P2093
P2860
P356
P1433
P1476
Interferon regulatory factor 3 ...... parenchymal and myeloid cells
@en
P2093
Angela Dolganiuc
Bharath Nath
Donna Catalano
Evelyn Kurt-Jones
Gyongyi Szabo
Jan Petrasek
Karen Kodys
Timea Csak
P2860
P304
P356
10.1002/HEP.24059
P407
P577
2011-01-10T00:00:00Z